PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Macrocyclic Compounds”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Exploring Mycobacterium avium inhibition by macrocyclic compounds.

Derivatives of synthetic macrocyclic compounds, MCC, 12- and 14-membered tetraazamacrocycles with N-pendant arms, such as N-methyl (Mepy14), N-acetate (DOTA, TETA and ac3py14) and N-methylphosphonate (DOTP) groups, were investigated in terms of their in vitro activity against Mycobacterium avium and for intracellular clearance, using the murine macrophage cell line J-774. Perspective results on a laboratory strain, of opaque morphology, showed in vitro activity with varying inhibitory patterns from one compound to another. The most active compounds, such as TETA, presented N-acetate pendant arms. Inhibition levels of 90% and above were obtained at 50 mg/l. Inhibition was confirmed with both the free compound and its iron(III) complex for DOTP, Mepy14, ac3py14, and TETA. However, with DOTA, no inhibitory effect was observed for the iron(III) complex, suggesting that chelation was at the origin of the inhibitory effect or that the donor atoms of the ligand were strongly involved. Nevertheless, simple experiments indicated that ferric ion might not be responsible for this reversed activity. Intracellular activity using 50 mg/l of TETA confirmed in vitro results with the laboratory strain. Results expressed as relative growth (%), of the drug-containing samples compared to control samples ranged from 2 to 123% (growth promotion) with no apparent relationship between inhibitory activity and the colony morphology of the strains. These studies showed that the evaluation of synthetic macrocycles may be relevant in development of a new family of compounds for use against M. avium infections.

Animals↗

New macrocyclic compound as chiral shift reagent for carboxylic acids.

[structure: see text] We have prepared a novel chiral macrocyclic compound 3 from a C2-symmetric aminonaphthol in a high yield. Enantiomeric acids have large nonequivalent chemical shifts (up to 0.80 ppm) in the presence of 3 in 1H NMR (500 MHz) spectra. Quantitative analyses of a series of mandelic acids with different enantiomeric purities show that host 3 is an excellent chemical shift reagent for chiral carboxylic acids.

Carboxylic Acids↗

Carboracycles: Macrocyclic Compounds Composed of Carborane Icosahedra Linked by Organic Bridging Groups.

A family of macrocyclic compounds are described, together with their precursors. These cycles are composed of icosahedral carboranes linked via their carbon vertices through 1,3-trimethylene, alpha,alpha'-1,3-xylylene, or alpha,alpha'-2,6-lutidylene groups. The compounds cyclo-(1,3-trimethylene-1',2'-closo-1',2'-C(2)B(10)H(10))(4) (6a), cyclo-(1,3-trimethylene-1',2'-closo-9',12'-dimethyl-1',2'-C(2)B(10)H(8))(4) (6b), cyclo-(1,3-trimethylene-1',2'-closo-1',2'-C(2)B(10)H(10))(3) (9), cyclo-(alpha,alpha'-1,3-xylylene-1',2'-closo-1',2'-C(2)B(10)H(10))(2) (11a), cyclo-(alpha,alpha'-1,3-xylylene-1',7'-closo-1',7'-C(2)B(10)H(10))(2) (11b), cyclo-(alpha,alpha'-1,3-xylylene-1',7'-closo-9',10'-dimethyl-1,7-C(2)B(10)H(8))(2) (11c), cyclo-(alpha,alpha'-1,3-xylylene-1',2'-closo-1',2'-C(2)B(10)H(10))(4) (12), cyclo-(alpha,alpha'-1,3-xylylene-1',7'-closo-1',7'-C(2)B(10)H(10))(3) (13), cyclo-(alpha,alpha'-2,6-lutidylene-1',7'-closo-1',7'-C(2)B(10)H(10))(2) (19), and cyclo-(alpha,alpha'-2,6-lutidylene N-oxide-1',7'-closo-1',7'-C(2)B(10)H(10))(2) (20) have been synthesized. The structures of 6a, 6b, 9, 11a, 11b, 11c, 12, and 19 have been determined by X-ray crystallography. Crystal data: for 6a, triclinic, space group P&onemacr;, a = 11.131(2) Å, b = 12.642(2) Å, c = 12.996(2) Å, alpha = 84.383(6) degrees, beta = 65.884(6) degrees, gamma = 97.292(5) degrees, Z = 1, R = 0.079; for 6b, monoclinic, space group P2(1)/a, a = 13.500(2) Å, b = 31.141(3) Å, c = 13.831(2) Å, beta = 99.90(1) degrees, Z = 2, R = 0.097; for 11a, monoclinic, space group C2/c, a = 14.5682(8) Å, b = 14.5046(8) Å, c = 16.1998(8) Å, beta = 95.631(2) degrees, Z = 4, R = 0.081; for 11b, monoclinic, space group P2(1)/n, a = 11.650(2) Å, b = 10.606(2) Å, c = 11.730(2) Å, beta = 104.951(6) degrees, Z = 2, R = 0.069; for 11c, orthorhombic, space group Pbca, a = 12.532(2) Å, b = 14.271(2) Å, c = 18.143(3) Å, Z = 4, R = 0.076; for 19, orthorhombic, space group Pcab (No. 61, standard setting Pbca), a = 11.0428(6) Å, b = 11.3785(6) Å, c = 22.533(1) Å, Z = 4, R = 0.074.

Journal Article↗

[Quantitative dependence of structure-antiseizure activity in a series of macrocyclic compounds].

In the present study we have further examined the influence of some structure parameters of macrocyclic polyethers upon their anticonvulsant activity in order to determine basic pharmacophore fragments. The anticonvulsant activity was studied experimentally for 25 new macrocyclic compounds, and their structure, physico-chemical properties, electron donor factors and atom charges were calculated using programs HyperChem-ChemPlus and HYBOT. The data about atomic properties were presented as a set functions of inter-atomic distances (Program MOLTRA). The cluster analysis revealed that studied compounds represent two independent groups which differ from chemical and pharmacological viewpoints. For first group, we have found that anticonvulsant activity of macrocycles is determined by their polarizability and spatial orientation of electron donor atoms. For another cluster the correlation was found between activity and spatial orientation of two hydrophobic fragments and electron donor atoms as well.

Animals↗

Interaction and cleavage of DNA with metal complexes of macrocyclic compound consisting of two 1, 10-phenanthroline.

We have synthesized two metal complexes of the macrocyclic compound (III, IV), with which either Cu2+ or Ru2+ is coordinated, consisting of two 1,10-phenanthroline molecules bridged by sulfur. Interaction of the metal complexes with DNA was examined by spectroscopic method and their binding constants were determined. The DNA cleaving activities of these complexes were also investigated.

Copper↗

Complex formation of cyclomaltononaose delta-cyclodextrin (delta-CD) with macrocyclic compounds.

The complex forming ability of delta-cyclodextrin delta-CD with 7 kinds of macrocyclic compounds (MCCs) with 8-15 carbon atoms in the ring as models of large guest molecules was studied in aqueous solution and compared with the complexation properties of alpha-, beta- and gamma-CD. Both alpha- and beta-CD formed relatively stable complexes with small MCCs, while gamma- and delta-CD were more efficient in binding larger MCCs. The solid MCC/delta-CD complexes were precipitated with the larger MCCs with 11-15 carbon atoms in the ring, while no such precipitates were obtained with smaller MCCs with only 8-10 carbon atoms in the ring. The formation of the solid complexes was confirmed by powder X-ray diffractometry and differential scanning calorimetry. The cell dimensions of cycloundecanone (11 carbon atoms in the ring)/delta-CD complex were determined by X-ray crystallography. The preliminary crystal data were: Monoclinic, P21, a=32.50 (2)A, b=19.02 (3)A, c=16.60 (1) A, beta3=98.37 (5)degrees, V=10148 (16) A3.

Crystallography, X-Ray↗

Partitioning of macrocyclic compounds in a cationic and an anionic micellar solution: a small-angle neutron scattering study.

Following a previous investigation on partitioning of some macrocycle compounds in sodium dodecyl sulfate (SDS) and dodecyltrimethylammonium bromide (DTAB) aqueous solutions and their effect on the micellar structure, a small-angle neutron scattering (SANS) study has been performed at fixed surfactant content (0.20 mol/L) and varying macrocycle concentrations from 0.20 up to 1.0 mol/L. Conductivity measurements have been also performed in order to evaluate the effect of the presence of macrocycles on the critical micellar concentration (cmc) of the two surfactants. SANS experimental data were fitted successfully by means of a core-plus-shell monodisperse prolate ellipsoid model. It has been found that 1,4,7,10,13,16-esaoxacyclooctadecane (18C6) and 4,7,13,16-tetraoxa-1,10-diazacyclooctadecane (22) do not interact with DTAB micelles whereas their sodium complexes interact with SDS aggregates and partially localize, as a consequence of electrostatic interaction, on the micellar surface or in the Stern layer. 2,5,8,11,14,17-Hexaoxabicyclo[16.4.0] dicosane (B18C6), as a consequence of the increased hydrophobic character with respect to 18C6, interacts with DTAB hydrocarbon chains and partially localizes in the inner part of micelles. This finding has been successfully used to justify the higher amount of B18C6 compared to the 18C6 one found in the SDS micellar phase. The substituted crown ether has been found localized both on the micelle surface via complex formation and in the inner part of micelles as a consequence of the increased hydrophobic character. For all systems, the aggregate size primarily decreases with the amount of macrocycle in the micellar phase. The interpretation of cmc trends as a function ofmacrocycle concentration gives information on its distribution between micellar and aqueous phases that is in line with SANS results.

Journal Article↗

Syntheses of novel 4-tert-alkyl ether proline-based 16- and 17-membered macrocyclic compounds.

Starting from N-Cbz-4-hydroxyproline methyl ester 1, a boron trifluoride-diethyl etherate-catalyzed reaction provided 4-tert-alkyl ether proline 4. Two deprotections and amide bond formations furnished the phenol alcohol 2. The macrocyclization of 2 was accomplished through a Mitsunobu reaction using triphenylphosphine and 1,1'-(azodicarbonyl)dipiperidine (ADDP), to afford novel 16- and 17-membered proline-based macrocyclic compounds of type 3.

Combinatorial Chemistry Techniques↗

Self-assembly of diorganotin(IV) moieties and 2-pyrazinecarboxylic acid: syntheses, characterizations and crystal structures of monomeric, polymeric or trinuclear macrocyclic compounds.

A series of diorganotin(IV) compounds of the type [R(2)Sn(pca)Cl](3)(R = CH(3); (n)Bu; C(6)H(5); C(6)H(5)CH(2); Hpca = 2-pyrazinecarboxylic acid), R(2)Sn(pca)(2)(mH(2)O)xnH(2)O (m= 1: R = CH(3), n= 2, R =(n)Bu, n= 0; m= 0, n= 0: R =(n)Bu, C(6)H(5), C(6)H(5)CH(2)) and (Et(3)NH)(+)[R(2)Sn(pca)(2)Cl](-)xmH(2)O (m= 0: R = CH(3), (n)Bu, C(6)H(5)CH(2); m= 1: R = C(6)H(5)) have been obtained by reactions of 2-pyrazinecarboxylic acid with diorganotin(iv) dichloride in the presence of sodium ethoxide or triethylamine. All compounds were characterized by elemental, IR and NMR spectra analyses. Except for compounds, and, the others were also characterized by X-ray crystallography diffraction analyses, which revealed that compounds and were trinuclear macrocyclic structures with six-coordinate tin(IV) atoms, compounds and were monomeric structures with seven-coordinate tin(IV) atoms, compounds and were polymeric chain structures with seven-coordinate tin(IV) atoms and compounds and were stannate with seven-coordinate tin(IV) atoms.

Journal Article↗

3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.

A series of macrocyclic 3-aminopyrrolidinone farnesyltransferase inhibitors (FTIs) has been synthesized. Compared with previously described linear 3-aminopyrrolidinone FTIs such as compound 1, macrocycles such as 49 combined improved pharmacokinetic properties with a reduced potential for side effects. In dogs, oral bioavailability was good to excellent, and increases in plasma half-life were due to attenuated clearance. It was observed that in vivo clearance correlated with the flexibility of the molecules and this concept proved useful in the design of FTIs that exhibited low clearance, such as FTI 78. X-ray crystal structures of compounds 49 and 66 complexed with farnesyltransferase (FTase)-farnesyl diphosphate (FPP) were determined, and they provide details of the key interactions in such ternary complexes. Optimization of this 3-aminopyrrolidinone series of compounds led to significant increases in potency, providing 83 and 85, the most potent inhibitors of FTase in cells described to date.

Alkyl and Aryl Transferases↗

Diastereoisomeric singly bridged cyclophosphazene-macrocyclic compounds.

31P NMR spectroscopy and added chiral shift reagent (CSR) or chiral solvating agent (CSA) have been used to show that unsymmetrically substituted singly bridged macrocyclic phosphazene compounds exist as 1:1 diastereoisomers of two racemic mixtures, in contrast to previous work (ref 2) on symmetrically substituted diastereoisomeric analogues, which exist as meso and racemic forms. The cis-ansa cyclotriphosphazatriene-macrocycle, 1, is meso and monosubstitution of the >P(O-macrocycle)Cl group with 2-naphthol gives a racemic product (7), in which the macrocyclic ring exists in a trans-ansa configuration. Reaction of 7 with the di-secondary amine, piperazine, gives an unsymmetrically disubstituted racemic compound (8) having a cis-ansa configuration of the macrocyclic ring. Reaction of 8 with a further quantity of 1 forms a singly bridged derivative (9) with the macrocyclic rings in cis-trans configurations, and further reaction of 9 with pyrrolidine gives compound 10 with the macrocyclic rings in cis-cis configurations. Both 9 and 10 have four stereogenic centers giving rise to diastereoisomeric compounds existing as mixtures of two racemates. The results are consistent with inversion of configuration at phosphorus at each step of the reaction of >P(OR)Cl groups with nucleophile Z (i.e., Z = naphthoxy, piperazino, pyrrolidino) to form >P(OR)Z derivatives.

Journal Article↗

Polyhalogenated heterocyclic compounds. Macrocycles from perfluoro-4-isopropylpyridine.

Perfluoro-4-isopropylpyridine was used as a building block for the two-step synthesis of a variety of macrocyclic systems bearing pyridine sub-units which were characterised by X-ray crystallography. Electrospray mass spectrometry revealed that complexation of either cations and, unusually, anions is possible depending on the structure of the macrocycle.

Anions↗

Lone pair effect in thallium(I) macrocyclic compounds.

The role of the inert (lone) pair of electrons in thallium(I) salts is studied by comparison of the compounds [Tl@18-crown-6]+ X- (X = TlI4, ClO4) and [K@18-crown-6]+ ClO4-. In contrast to common introductory chemistry textbook opinions, the paradigm that s-p hybridization is a prerequisite for an inert electron pair to become stereochemically active in compounds of the heavier main group elements has to be revised. Instead, an inert pair of electrons is expected to become stereochemically involved whenever it is forced to participate in antibonding orbital interactions with its surroundings, and there is the possibility for a structural distortion that minimizes these repulsive forces. The structural distortion will occur to such an extent that repulsive orbital interactions and attractive electrostatic interactions counterbalance. Our results also provide an explanatory background for many of the rules of thumb that are found in the literature about why and when an inert electron pair is expected to become stereochemically active in a certain compound.

Journal Article↗

[Synthesis and spectroscopic studies of new N-functionalized macrocyclic compounds and complex].

Three new N-functionalized tetraazamacrocyclic compounds, C-messo-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane- N,N',N",N'"-tetrakis (ethyl acetate) (A), C-messo-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetra- azacyclotetradecane-N,N,'N",N'"-tetraacetic acid (H4L) and the hydrobromide of H4L have been synthesized and the complex Na2[NiL].2C2H5OH has been prepared as well. The macroyclic compounds and the complex have been studied by electronic spectrum, infrared spectrum, 1H NMR, MS and elemental analysis.

English Abstract↗